[ad_1]
Hotel giant expects to report adjusted profit of $2.27 a share to $2.33 a share, below the analyst estimate of $2.38 a share.
[ad_2]
Source link
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March...